The use of personal computers and software programs as clinical aids for intervening with various health issues is increasing. This project evaluated the perceived attributes, utilization, and adoption of an automated computer-based software program for problem drinkers by 22 treatment providers across 10 predominantly state-funded, outpatient addiction treatment agencies in New Mexico. Results demonstrated that treatment provider ratings, utilization, and adoption of the program were modest, despite initial enthusiasm on the part of agency directors regarding the program. Implications regarding dissemination efforts, in general, are discussed.
T he utility of personal computers (PCs) and software programs in clinical practice is fast moving beyond simple assessment and into the realm of aiding clinicians in addressing a wide range of psychologic issues with increasing sophistication. [1] [2] [3] [4] [5] [6] Clients have reported that they are often more willing to initially disclose sensitive information within the context of a computer program [7] [8] [9] and engaging programs that offer personalized, objective feedback about specific behaviors have the potential to stimulate client interest in a number of topic areas. 3, 5 Software programs may also represent an effective mechanism to offer lowcost, preliminary interventions to a greater number of individuals-many of whom may not receive services otherwise.
Another potential benefit related to the use of PCs in clinical practice is the ease of data management they provide. With increasing emphasis on the evaluation of treatment outcome, the need for organized data management is growing. However, for many clinicians and treatment administrators, managing outcome data and generating summary analyses can be cumbersome. Although the collection and scoring of assessment data via PCs is already common practice for many assessment instruments, the organization of multiple assessments into meaningful, summarized data is not. Computer programs designed to go beyond simple collection and scoring by combining the ability to actively manage data, conduct analyses, and produce structured reports may be useful to clinicians and administrators alike.
One treatment area poised to benefit from the use of computer programs is addictive behaviors. Over the past 15 years, brief interventions that seek to enhance motivation for changing addictive behavior have been developed and evaluated in a number of diverse clinical settings including emergency rooms, inpatient medical programs, as a prelude to inpatient or outpatient substance abuse treatment, as a mail order self-help program, and within general clinical practice. [10] [11] [12] [13] Given the demonstrated effectiveness of brief interventions for alcohol use disorders, 14, 15 another potentially effective delivery alternative is to use PCs to conduct assessments, generate feedback, and offer other brief intervention strategies.
Recent work in the area of PC-based interventions for problem drinkers conducted by Hester and colleagues 2, 3, 16, 17 has led to the development of a program based on the original Drinker's Check-up intervention created by Miller et al. 18 The program is referred to here as the Computerized Drinker's Check-up (CDCU). The CDCU, like other brief interventions, is specifically designed to assist individuals ambivalent about change. It provides comprehensive assessment of drinking, objective feedback, and encourages the exploration of new alternatives to drinking and other addictive behavior within a functional analytic framework. The CDCU also contains a component program called the Follow-up Drinker's Check-up (FDCU), which was developed to allow treatment providers to conduct follow-up assessments at 1, 2, or 3 time points to evaluate changes in drinking. An overview of the CDCU/FDCU can be found in Squires and Hester. 16 Although programs like the CDCU may provide benefits to both clients and treatment providers, utility alone does little to promote the adoption of innovations in practical settings. 19 In examining factors affecting the process of diffusing innovations over several decades, Rogers 19 identified 5 perceived attributes of innovations that seem to reliably predict adoption behavior. These attributes include relative advantage (the degree to which an innovation is perceived of as offering specific advantages over existing practice), compatibility (the degree to which an innovation is perceived to be consistent with the values, experiences, and needs of those who are considering adopting it), complexity (the degree to which an innovation is perceived to be difficult to understand or use), trialability (the degree to which potential adopters can experiment with an innovation before making a decision to adopt it), and observability (the degree to which the benefits associated with an innovation are observable to others). Subsequent research spanning 4 decades has shown that these 5 factors alone typically account for between one-half and nearly 90% of the variance associated with rates of adoption across a range of innovations. 19 
PURPOSE OF THE STUDY
The primary purpose of the project was to promote the adoption of the CDCU across a sample of outpatient addiction treatment agencies located throughout New Mexico. As part of the process, we assessed the degree to which the program was used with clients across agencies and how agency staff perceived the CDCU in terms of the 5 perceived attributes outlined by Rogers. 19 The study also piloted a novel method of using a customized clinical demonstration trial nested within each participating agency to promote initial use of the program.
METHODS

Participants
Eleven licensed treatment provider agencies from across the state of New Mexico were recruited to evaluate the attributes and adoption of the CDCU. The 11 agencies were predominantly state-funded, outpatient treatment programs, rooted in a 12-step treatment tradition. As a condition of participation, each of these agencies agreed to conduct a small, 2-group (standard treatment plus the CDCU vs. standard treatment only) demonstration trial of the CDCU involving willing participants presenting for alcohol-related treatment. The demonstration trial was primarily intended to promote familiarization with the program.
Initial Recruitment of Treatment Agencies
To identify treatment agencies that would be interested in participating in the project, a general announcement was sent out via e-mail to a listing of state-funded alcohol treatment organizations. Agencies were offered incentives including a complimentary copy of the CDCU software with unlimited program updates and technical support for the duration of the study and a free 6-hour workshop worth 6 continuing education credits. The workshop covered both use of the program and basic elements of conducting program evaluation.
Overall, recruitment and training of 11 total agencies that volunteered for the study took approximately 6 months to achieve. One of the agencies, however, chose to withdraw from participation after having been trained, but before beginning the study protocol. A unique aspect of this agency is that it was the only one for which interest in participation had been advanced by an affiliated third party, and not by the director of the program. It was also the only agency at which the director was unwilling to sign a letter of commitment at the time of training. Characteristics of the final sample of 10 agencies are detailed below in the results section.
Materials
Agency directors completed a simple demographic survey regarding agency characteristics (size, treatment philosophy, average number of annual referrals, and so on), and all participating treatment staff completed a questionnaire designed to assess each of the 5 perceived attributes of the CDCU during the final month of the project.
Perceived Attributes Scale
An instrument developed by Moore and Benbasat 20 was used to measure treatment providers' perceptions of the CDCU. The 27-item, customizable scale is referred to here as the Perceived Attributes Scale (PAS). The PAS measures the 5 diffusion attributes of relative advantage, compatibility, complexity, trialability, and observability. The scale uses 7-point Likert scales for each question ranging from 1 (strongly disagree) to 7 (strongly agree). A rating of 4 is considered neutral. The scale demonstrates a high degree of construct, content, and criterion validity, along with acceptable internal consistency and test-retest reliability.
Procedure
Study Design
The study employed a 1-year design, which included an initial 6-month phase for recruiting and following up with demonstration trial participants, and a subsequent 6-month period for discretionary use of the CDCU. Primary administrators responsible for the oversight of services and management of clinical practice (most commonly agency directors) served as primary contacts at all of the agencies. In addition to the agency directors, staff treatment providers also participated. During the training workshop, agency directors reviewed and signed a nonbinding contract outlining the specific benefits and responsibilities related to participation.
To facilitate timely progression of study milestones at each agency, regular meetings (phone or in-person) between the first author and treatment directors and/or clinical staff were scheduled to address any issues or concerns. Study procedures were approved by the University of New Mexico Institutional Review Board.
RESULTS
Agency Characteristics
Participating agencies ranged in size from 1 to 25 staff. The projected average number of clients seen per year for alcohol-related problems was 187, with a range of 50 to 400. Four of the agencies were classified as ''rural.'' On a Likert scale ranging from 1 (confrontational) to 7 (empathic) in terms of the agency's overall treatment philosophy, the average score as reported by agency directors was 5.5 (SD = 0.85), indicating a preference toward empathic treatment approaches. In all cases, the agency director also had clinical responsibilities within the organization. Finally, all 10 agencies dealt largely, if not exclusively, with publicly funded and/or adjudicated populations.
Altogether, 22 treatment providers participated in the study across the 10 agencies. Collectively, the agencies agreed to recruit a total of 118 participants for the demonstration trial. As can be seen in Table 1 , however, although all participating agencies made an effort to recruit demonstration trial participants, only 2 of the 10 agencies actually recruited the full number of agreed-upon clients in the time allotted. Though most agencies failed to recruit the full number of agreed-upon demonstration trial participants, they were nonetheless encouraged to integrate the CDCU into practice during the second 6 months of the project. However, only 6 of the 10 treatment programs made efforts to use the CDCU during this time. Overall use of the program (including both demonstration trial and subsequent discretionary use) at each agency ranged from nearly 0 (0.5%) to 18.6% of the total expected annual alcohol-related client referrals. Use of the CDCU was confirmed by objective review of the CDCU database log file.
PAS Reliability and Tests of Critical Assumptions
Although the small sample size of treatment providers did not allow for the use of factor analysis to confirm the structure of the revised Moore and Benbasat scale, internal consistency was evaluated. To evaluate the overall internal consistency reliability of the PAS for the present sample of 22 counselors, 2 separate estimates of reliability were computed: coefficient a and a split-half coefficient expressed as a Spearman-Brown corrected correlation. For the split-half coefficient, the scale was divided between even and odd items. Because this produced an unequal number of items, the value for the unequal-length Spearman-Brown statistic was used. Values for both coefficient a and the split-half coefficient were similar at 0.84 and 0.89, respectively, indicating acceptable full-scale reliability.
In addition to full-scale estimates of reliability, internal consistency reliabilities for each of the 5 PAS subscales were also computed. Results indicated acceptable coefficient a for relative advantage on the basis of 7 items (0.91), complexity on the basis of 6 items (0.79), and observability on the basis of 4 items (0.77). Reliability was questionable for compatibility on the basis of 4 items (0.60) and clearly unacceptable for trialability on the basis of only 2 items (0.45). However, given the small number of items for trialability, this was likely an underestimate of the actual reliability. The distribution of the 5 attribute subscales across the sample of treatment providers was approximately normal.
Evaluation of PAS Subscales
Beyond basic psychometric properties of the PAS, interrelationships between each of the subscales were also evaluated to confirm expectations that complexity would be the only scale negatively related to each of the others. As can be seen in Table 2 , the expected relationships were observed. Finally, treatment providers' average evaluation of the 5 attributes of the CDCU across agencies was quantified. Items specific to each attribute were scored using 7-point Likert scales, where a score of 1 indicated strong disagreement and a score of 7 indicated strong agreement. A score of 4 was considered neutral. The average per item rating across agencies for relative advantage was 4.7 (SD = 0.95), compatibility was 4.9 (SD = 0.91), complexity was 3.3 (SD = 0.92), observability was 4.4 (SD = 1.4), and trialability was 4.8 (SD = 1.2). Average per item ratings for the agency directors only across agencies were also computed to evaluate if there were any differences from pooled ratings including all participating treatment providers. When including only agency directors, the average per item rating for relative advantage was 5.3 (SD = 0.78), compatibility was 5.4 (SD = 0.49), complexity was 3.0 (SD = 0.94), observability was 4.9 (SD = 1.0), and trialability was 5.3 (SD = 1.1).
Utilization and Adoption of the CDCU
A primary aim of the study was to assess how treatment staff not only perceived the CDCU, but if, and to what degree, the program would be used with clients for both demonstration trial and postdemonstration trial (adoption) purposes across the agencies. Although the small sample size of the study did not provide sufficient power to conduct regression analyses to evaluate the predictive relationship between the perceived attributes of the CDCU and subsequent utilization and adoption of the program, we did compute simple bivariate correlations to establish the direction and magnitude of the relationship between each of the 5 perceived attributes and the total number of clients (for both the demonstration trial and subsequent posttrial adoption) that each of the 22 participating providers used the program with. As can be seen in Table 3 , each of the 5 perceived attributes related to use of the program with clients in the expected directions, with complexity being the only factor negatively related.
Given the small sample, only 1 of the attributes, observability, was significantly correlated with use of the program with clients, despite moderate correlation coefficients for relative advantage, compatibility, and trialability as well.
In addition to examining use of the CDCU program with all clients (for both demonstration trial and subsequent adoption purposes), we were also interested in quantifying the amount of postdemonstration trial use of the CDCU, or ''adoption'' during the 6-month discretionary use period. There was significant variability in terms of adoption of the CDCU across agencies, and the distribution was heavily skewed and bimodal (skewness statistic of 2.7) across sites. Agencies ranged from 0% to 22.6% in terms of adoption use on the basis of the total expected referrals listed in Table 1 .
Given the outlier status of 1 agency that adopted and used the CDCU with 22.6% of expected annual referrals in only 6 months, we evaluated whether the average per item ratings of the perceived attributes of the CDCU from this agency differed from the others. However, there were no significant differences between ratings from the outlier and remaining agencies, indicating that differences in adoption between the outlier and other agencies were not likely attributable to differential ratings of the perceived attributes of the CDCU.
DISCUSSION
The primary goal of the study was to evaluate the perceived attributes, utilization, and adoption of a novel PC-based intervention for problem drinkers across 10 diverse treatment agencies. Ratings of the perceived attributes of the CDCU were made by 22 treatment providers, and adoption of the program was quantified across the 10 participating agencies. Overall, ratings regarding the perceived attributes of the CDCU across treatment agencies were relatively neutral with respect to assessment of each of the 5 perceived attributes of the program, and only observability was significantly related to overall utilization. Subsequent adoption of the program into routine practice was modest. Although these findings are somewhat disappointing given initial interest in the program by agency directors, they are congruent with other work documenting the complexity inherent in effectively disseminating novel interventions. 19, 21, 22 Average per item ratings of the perceived attributes of the program across agencies were less supportive than expected. However, attribute ratings of the program made by agency directors were more supportive of the program than those of treatment providers only. This is an important discrepancy, and indicates that agency treatment staff in nonmanagement positions perceived the CDCU as less beneficial than decision makers. Although this finding is not particularly surprising given that agency directors made the initial decision and commitment to participate in the project, it highlights a frequent, and often problematic, bidirectional discrepancy between decision makers and front-line staff within agencies, where differential priorities moderate the complicated process of approaching and adopting new practices. 19 Another issue that may have affected the perceived attributes was 2 pronged-lack of adequate incentives to inspire sustained interest in the program, coupled with the additional demands of conducting a demonstration trial of the program with clients. In the current study, there were few substantial proximate incentives for treatment providers to use the program outside of endorsement from agency directors once delivery of the initial continuing education credits was complete. Even in the case of agency directors, primary interest in the program was often tied to the ''potential'' for improved ability to collect outcome data that could then be used to apply for added or continued funding for treatment programs. Unfortunately, because these advantages were distal and probabilistic, they may have been insufficient to promote sustained interest.
As for the demonstration trial, although every attempt was made to minimize the added burden of conducting the trial, there were unavoidable demands placed on providers to obtain consent, administer additional measures, and budget effort for other related responsibilities that extended well-beyond existing daily demands. Although the intention of the trial was to promote familiarity of the program while introducing the practice of outcome evaluation, the added burden may well have had the unintended effect of decreasing the perceived benefit of the CDCU and discouraging use of the program altogether. Indeed, other research has demonstrated subject reactivity to tasks extraneous to the intervention itself. 23 Despite these issues, 1 of the 10 agencies, which was 1 of only 2 to recruit the total number of agreed-upon demonstration trial participants, adopted the program at a much higher rate than the others. Anecdotally, however, this was the only agency at which the CDCU was integrated into practice as a standard part of the intake procedure as initiated by the agency director. Given the stand-alone capability of the program, it may have required such a low degree of effort to ''adopt'' in this fashion that the otherwise neutral ratings of the perceived attributes had less of an impact than they otherwise would have if use of the program had been left to individual choice.
Finally, one can simply not ignore the possibility that the lackluster ratings and subsequent lukewarm utilization and adoption of the CDCU were simply reflective of the program itself. It may, therefore, have been the case that regardless of what could have been carried out to better promote and support the CDCU, the program would have simply failed to appeal to the agencies and providers that participated in the study.
Implications for Dissemination
If the decision to adopt a given innovation is typically made within a stage-based process of readiness for change, 19 it may be that innovations for which adoption is encouraged via authority-based methods run an increased risk of promoting resistance among potential adopters in much the same way that lobbying for change increases the likelihood of resistance in the clinical sense. 24, 25 Therefore, in cases where authority-based innovation-decision structures are used to promote the use of novel treatment innovations, it may be crucial that innovations not only be carefully developed in a collaborative fashion so as to be congruent with existing value systems and needs, but that readiness for change at both the individual and organizational levels be assessed and addressed more effectively than it was in the current study. 26, 27 Although findings related to the perceived attributes of the CDCU indicated that providers were neutral in their ratings of the program, these ratings may have been influenced by factors other than those specific to just the program. Rogers 19 characterized 5 distinct categories of adopters including (a) innovators, (b) early adopters, (c) early majority, (d) late majority, and (e) laggards. On the basis of these categories, perception of attributes and subsequent adoption of any innovation is likely to depend heavily upon which adopter characteristics are most prevalent in the target population or organization. For example, if an innovation is promoted in an environment primarily comprised of individuals in the ''late majority,'' then one might expect initial rates of interest and adoption to be lower than if the innovation were promoted in an environment comprised primarily of ''early'' adopters. This may have been relevant in the current study.
Another important component of change at the organizational level may be a broader menu of change options. In fact, matching needs (and values) with appropriately tailored interventions has been identified as an important element of successful dissemination of empirically supported treatments, 28 and has long been a core element of several prominent models of behavior change. 19, 25, [29] [30] [31] Dissemination efforts that not only assess readiness for change, but that also address practical issues regarding the ability to make those changes through a range of choices, may yield the highest probability of successful and sustained adoption of novel methods. For example, if the CDCU could have addressed specific components of a provider's ''existing'' workload (eg, collecting already required assessment information), perhaps the response to it would have been more favorable. Indeed, Miller and colleagues 32 offer a specific challenge to develop dissemination strategies that are more congruent with what is known about individual-level change processes.
Lastly, providing organizations with objective feedback may be 1 way to promote organizational readiness for change. Feedback has been identified in individual interventions as a crucial component for increasing readiness for change by developing a discrepancy between where an individual is, respective to where they would like to be. 33 Perhaps feedback structured for organizations (eg, data from program evaluation, cost effectiveness, etc.) when given in a constructive, collaborative manner could function to increase readiness for change in much the same way that it does for individuals. Although the current study piloted a demonstration trial that eventually produced treatment outcome data supporting the efficacy of the program across agencies, feedback regarding aggregate utility was not made available to the agencies. Instead, each agency had access to the outcome data from their site only.
Limitations
The present study used a crosssectional design with a small sample of predominantly state-funded, outpatient addiction treatment programs from the state of New Mexico. Accordingly, the results are preliminary and descriptive in nature.
One issue that may have specifically impacted the ''compatibility'' of the program at some agencies is that it was available in an English-only language version at the time the project was conducted. Given the substantial ethnic diversity of New Mexico, this may have been an issue at a few agencies where a percentage of clients spoke Spanish only. Although providers were encouraged to translate for participants who had difficulty with English, this was not likely a practical alternative. There is, however, a Spanish language version of the CDCU now available.
There were also measurement limitations. The perceived attributes were measured cross-sectionally at the end of the study. Future studies that evaluate innovate practices should assess the perceived attributes at regular intervals to allow for prospective evaluation. Indeed, Rogers 19 suggests that repeated measurement of attributes is desirable in that it affords researchers the added ability of evaluating trends in perception over time. Another benefit to conducting not only pre-post assessment of perceived attributes, but doing so even at regular intervals while dissemination efforts are underway, is that it could identify areas in need of attention and/or intervention in an iterative fashion. Reliance on a cross-sectional, 5point Likert scale as the only measure of the perceived attributes was also limiting, and did not provide information about barriers to using the CDCU.
Finally, adoption rates for the CDCU may have been overly conservative given that they were based on projected rates of annual alcohol-related referrals at each agency. The rates might have been better if it had been possible to estimate how many patients with alcohol issues actually entered treatment during the study period.
CONCLUSIONS
Although the use of PCs and Internet-based programs as clinical aids for intervening with various health issues is increasing, the present study failed to provide clear support for the CDCU across a small sample of addiction treatment agencies in New Mexico. Future research with larger samples and prospective designs should continue to examine the specific roles that computer-based assessment and intervention programs might fulfill and should also explore the differential utility of these programs across a broader range of target populations, including administrators, treatment providers, patients/ clients, and other relevant stakeholders.
